FIELD: organic chemistry, pharmacology. SUBSTANCE: invention describes novel compounds of the formula (I) or their pharmaceutically acceptable salts where X is O; Y is N; 7 is O, S, N-R15, k and z-c or N under condition that one of their is C; p = 0, 1; R' is hydrogen atom, lower alkyl, the group Z4-NR6R7 where Z4 means the group Z9COZ10 and each of Z4,Z9,Z10 means a single bond; R6 is hydrogen atom, alkyl; R7 is hydrogen atom; R2 is hydrogen atom or lower alkyl; R3 and R4 each is lower alkyl; each of R12,R13,R14 is hydrogen atom; R15 is hydrogen atom, alkyl, hydroxyethoxymethyl, methoxyethoxymethyl; R11 is hydrogen atom, hydroxyl, CO2R5 where R5 is alkyl, oxazolyl, alkenyl substituted with phenyl; Z4 is NR6R7 where Z4 means Z9COZ10 where Z9 and Z10 each means a single bond; R6 and R7 are given above; alkyl substituted with the group Z2 where Z2 is hydroxyl, the group where Z4 is a bond; Z5 is groups Z9COZ10,Z9COOZ10,Z9S(O)nZ10; Z9,Z10 each a single bond; Z11 is hydrogen, alkyl; Z6 is hydrogen, alkyl, phenyl, phenyl substituted with one halogen atom, alkyl substituted with three halogen atoms; n = 2, or Z2 means the group where Z4 is a single bond; Z5 is the group Z9COZ10 where Z9 and Z10 mean a single bond; Z9 is hydrogen atom; Z8 is alkyl, phenyl; Z11 is hydrogen, alkyl. Compounds are antagonists of endothelin. EFFECT: new compounds indicated above, valuable pharmacological properties. 15 cl, 1 tbl, 43 ex
Title |
Year |
Author |
Number |
SUBSTITUTED BIPHENYLSULFONAMIDES, PHARMACEUTICAL COMPOSITION BASED ON THESE COMPOUNDS, AND METHOD FOR ANTAGONISTIC ACTION OF ENDOTHELIN |
1996 |
- Nehtesehn Murugesehn
- Dzhoel K. Behrrish
- Filip D. Stejn
|
RU2159770C2 |
ISOXAZOLE PHENYLSULFONAMIDE DERIVATIVES AND METHOD OF MEDICAL TREATMENT |
1993 |
- Natesan Murugesan
- Dzhon T.Khant
|
RU2133742C1 |
METHODS FOR PREPARING BIPHENYLISOXAZOLE SULFON- AMIDES |
1997 |
- Polnjazhek Richard P.
- Vang Ksuebao
- Depju Dzheffri S.
- Pandit Chennagiri R.
- Gadamasetti Kumar G.
- Pendri Jadagiri
- Martines Ehduardo Kh.
|
RU2209815C2 |
COMPOUNDS CONTAINING A CONDENSED BICYCLIC RING, INTERMEDIATE COMPOUNDS, METHODS OF THEIR SYNTHESIS, PHARMACEUTICAL COMPOSITION FOR INHIBITION OF ANGIOTENSIN-CONVERTING ENZYME AND NEUTRAL ENDOPEPTIDASE ACTIVITY |
1994 |
- Dzheffri A.Robl
- Dehvid R.Kronental
- Dzholli D.Godfrej
|
RU2125056C1 |
1,2,5-THIADIAZOLE DERIVATIVES OF INDOLYLALKYL-PYRIMIDINYL-PIPERAZINES AND PHARMACEUTICAL COMPOSITION BASED ON THESE COMPOUNDS |
1996 |
- Ronni R. Krenshou
- Ehdvard Kh. Rudiger
- Dehvid V. Smit
- Karola Solomon
- Dzhozef Jevich
|
RU2165420C2 |
DERIVATIVES OF OXAZOLE |
1992 |
|
RU2032677C1 |
SULFAMIDE COMPOUNDS OR THEIR PHARMACEUTICALLY ACCEPTABLE SALTS AND METHOD OF INHIBITION OF ET RECEPTORS |
1994 |
|
RU2141953C1 |
4-PYRIMIDINE- OR PYRIDINYL DERIVATIVES OF INDOLE-3-YL-ALKYLPIPERAZINES, PHARMACEUTICAL COMPOSITION |
1992 |
- Dehvid V.Smit
- Frehnk D.Vokka
- Dzhozef P.Evich
- Ronal'D Dzh.Mattson
- Ehndrju Uil'Jams
- Ehdvard Kh.Rudiger
- Kejt Din Kombrink
- Brehdli Klajd Pirs
|
RU2114111C1 |
ENDOTHELIN ANTAGONISTS: N-[[2'-[[(4,5-DIMETHYL-3-ISO-XAZOLYL)AMINO]SULFONYL]- 4-(2-OXAZOLYL)[1,1'-BIPHENYL]-2-YL]METHYL]-N,3,3-TRIMETHYLBUTANEAMIDE AND N-(4,5-DIMETHYL-3-ISOXAZOLYL)-2'-[(3,3-DIMETHYL-2-OXO-1- PYRROLIDINYL)METHYL]-4'-(2-OXAZOLYL)[1,1'-BIPHENYL]-2-SULFONEAMIDE AND THEIR SALTS |
1998 |
- Murugesehn Nehjtsehn
- Behrrish Dzhoel S.
- Gu Zhengksiang
- Morrison Richard A.
|
RU2183632C2 |
RETINOID-LIKE COMPOUNDS, PHARMACEUTICAL COMPOSITION, METHOD OF TREATMENT |
1996 |
- Dzhon E. Stehrrehtt Ml.
- Kuo-Long Ju.
- Muzammil M. Mansuri
- Dehvid R. Tortolani
- Peter R. Rezhek
|
RU2163590C2 |